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Abstract: While investigating the cytotoxic activity of the methanol extract of an 
Australian marine sponge Stelletta sp. (Demospongiae), a new diketopiperazine,  
cyclo-(4-S-hydroxy-R-proline-R-isoleucine) (1), was isolated together with the known 
bengamides; A (2), F (3), N (4), Y (5), and bengazoles; Z (6), C4 (7) and C6 (8). The 
isolation and structure elucidation of the diketopiperazine (1), together with the activity of 
1–8 against a panel of human and mammalian cell lines are discussed. 
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1. Introduction 
Since the first reported isolation of a diketopiperazine (DKP) from the sponge Dysidea herbacea [1], 
there have been several reports describing the isolation of this class of compound from other marine 
sponges [2–4]. DKPs are also reported from marine microbial sources [5–8], including the 
proteobacteria Alcaligenes faecalis, isolated from the sponge Stelletta tenuis [9]. The metabolites 
reported in these investigations are mostly the products of 4-hydroxy-proline [2,5,6,8] or proline [7] 
reacting with phenylalanine [2,5], arginine [4], leucine [5–7], isoleucine [7], norvaline [3] or alanine [8]. 
Sponges from the genus Stelletta are known to produce a number of other bioactive classes of 
compounds, including but not limited to steroids [10], alkaloids [11,12], isomalabaricane  
triterpenes [13], acetylenic acids [14] and lysophosphatidylcholines [15]. Initial interest in the 
methanol (MeOH) extract of the sponge Stelletta sp. was motivated by to its potent activity in the NCI 
60 cell line screen and a unique COMPARE analysis profile (average GI50 0.5 µg/mL) [16].  
This profile was different to that of the standard chemotherapeutic agents paclitaxel, cisplatin, 
gemcitadine, bryostatin 1, didemnin B, tamoxifen and vinblastine (data provided by NCI). Subsequent 
bioassay-guided investigations of this extract led to the isolation of a new DKP cyclo-(4-S-hydroxy-R-
proline-R-isoleucine) (1), the previously reported bengamides; A (2) [17], F (3) [18], N (4) [19], Y (5) [20], 
and the previously reported bengazoles; Z (6) [20], C4 (7) [21] and C6 (8) [21]. Described in this 
publication is the isolation and structure elucidation of 1, together with the activity of compounds 1–8. 
2. Results and Discussion 
The DKP cyclo-(4-S-hydroxy-R-proline-R-isoleucine) 1 was isolated and the molecular formula 
C11H18N2O3, corresponding to four double-bond equivalents, was determined by (+)-ESI-FTMS 
accurate mass measurement. The 13C NMR data of 1 contained resonances consistent with the 
presence of two amide carbonyl groups (δC 170.5 (C-7), 165.4 (C-1)) as the only multiple bonds within 
the molecule, and a hydroxy methine (δC 66.8 (C-4); δH 4.28, 1H, dd, J = 4.6, 4.6 Hz) (Table 1). These 
functionalities accounted for all of the oxygen and nitrogen atoms and all of the multiple bonds in 1, 
indicating the molecule to be bicyclic. Analysis of the COSY NMR data of 1 showed an extended  
1H–1H spin system from H-9 to H3-12 via H-10 and H-11, as well as a vicinal COSY NMR correlation 
from H-10 to H3-13. Observed gHMBC NMR correlations from δΗ 7.97 to the 13C NMR resonances at 
δC 59.1 (C-9), δC 56.7 (C-6), δC 34.8 (C-10) and C-1 positioned this hydrogen at N-8. Further gHMBC 
NMR correlations from δΗ 4.00 (H-9) to δC 23.9 (C-11) and δC 14.9 (C-13), as well as to C-1 and  
C-10, clearly positioned H-9 adjacent to the C-1 carbonyl and N-8, giving rise to an isoleucine moiety 
(1A). Additional gHMBC NMR correlations from 8-NH and H-9 to C-7 revealed it was attached to  
N-8. A further contiguous 1H–1H spin system from H-6 to H2-3, in addition to gHMBC NMR 
correlations from the 8-NH and Hb-3 to C-6, and from Hb-3 to C-1 established the remaining nitrogen 
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(N-2) to be attached to C-1, C-6 and C-3, giving rise to the two rings within 1. The planar structure of 
1 is as shown (Scheme 1). 
Table 1. NMR data for 1 (600 MHz, d6-DMSO), cyclo-[S-proline-S-isoleucine)] (300 MHz, 
CDCl3) and 1H NMR data for cyclo[L-(4-hydroxyprolinyl)-L-leucine)] (300 MHz, CD3OD). 
No. 
13C 
δ (m) 
1H δ (m, J Hz) COSY gHMBC 
1H δ (m, J Hz) of 
cyclo-[S-proline-
S-isoleucine)] [3] 
1H δ (m, J Hz)  
of cyclo[L-(4-
hydroxyprolinyl)-L-
leucine)] [6] 
1 165.4 (s)      
2       
3 53.8 (t) 
3.51 (1H, dd, 
12.5, 4.6) 
3.20 (1H, d, 12.5) 
Hb-3, H-4 
Ha-3 
C-1, C-4, C-5, C-6 
C-1, C-4, C-5, C-6 
3.6–3.5 (2H, m) 
3.65 (1H, dd, 12.5, 4.3) 
3.42 (1H, d, 12.5) 
4 66.8 (d) 
4.28 (1H, br dd, 
4.6, 4.6) 
Ha-3, 4-OH, Hb-5 C-3, C-6 
2.0–1.9 (1H, m) 
1.9–1.8 (1H, m) 
4.28 (1H, t, 4.3) 
4-OH  5.10 (OH, br s,) H-4  - - 
5 37.2 (t) 
2.03 (1H, dd, 
12.9, 6.1) 
1.88 (1H, ddd, 
12.9, 11.0, 4.6) 
Hb-5, H-6 
H-4, Ha-5, H-6 
C-3, C-4 
C-4, C-6, C-7 
2.3–2.2 (1H, m) 
2.1–2.0 (1H, m) 
2.27 (1H, dd, 13.3, 6.5) 
2.08 (1H, ddd, 13.3, 
11.1, 4.3) 
6 56.7 (d) 
4.31 (1H, dd, 
11.0, 6.1) 
H2-5 C-5, C-7 4.07 (1H, t, 7.5) 4.51 (1H, dd, 11.1, 6.5) 
7 170.5 (s)      
8-NH  7.97 (1H, s) H-9 
C-1, C-6, C-7,  
C-9, C-10 
5.99 (1H, br s) exchangeable 
9 59.1 (d) 4.00 (1H, br s) 8-NH (w), H-10 
C-1, C-7, C-10,  
C-11, C-13 
3.96 (1H, br s) 4.15 (1H, m) 
10 34.8 (d) 2.01 (1H, m) 
H-9, Hb-11,  
H3-13 
C-1, C-13, C-11 2.4–2.3 (1H, m) 
1.90 (1H, m) 
1.50 (1H, dd, 8.0) 
11 23.9 (t) 
1.32 (1H, qdd, 
11.8, 7.4, 4.5) 
1.26 (1H, qdd, 
11.8, 9.2, 7.2) 
Hb-11, H3-12 
H-10, Ha-11,  
H3-12 
C-9, C-10, C-12, 
C-13 
C-9, C-10, C-12, 
C-13 
1.5–1.4 (1H, m) 
1.3–1.1 (1H, m) 
1.88 (1H, m) 
12 12.3 (q) 0.82 (3H, t, 7.4) H2-11 C-10, C-11 0.92 (3H, t, 7.4) 0.95 (3H, d, 6.4) 
13 14.9 (q) 0.97 (3H, d, 7.0) H-10 C-9, C-10, C-11 1.05 (3H, d, 7.2) 0.96 (3H, d, 6.4) 
The configuration at C-4, C-6 and C-9 of 1 was established through analysis of 1H–1H coupling 
constants, optical rotation measurement, molecular minimisations and comparison with literature 
compounds [3,6,7]. The magnitude of the coupling constants associated with H-6 (dd, J = 11.0,  
6.1 Hz) and the observed COSY NMR correlations between H-6 and Ha/b-5 established it to have a  
pseudo-axial orientation, similar to that of cyclo[L-(4-hydroxyprolinyl)-L-leucine)] (H-6, dd, J = 11.1, 
6.1 Hz) [6]. An apparent zero coupling between H-4 (J = 4.6, 4.6 Hz) and Hb-3 or Ha-5 as evident by 
lack of observed COSY NMR correlations, and observed couplings to Ha-3 (J = 12.5, 4.6 Hz) and Hb-5 
(J = 12.9, 11.0, 4.6 Hz), was indicative of H-4 being orientated at approximately 90° to both Hb-3 and 
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Ha-5. The observed weak COSY NMR correlation between 8-NH and H-9, and the broad singlet for 
H-9 (similar to that observed in cyclo-[S-proline-S-isoleucine)] [3]), revealed H-9 to be axial. 
Molecular modelling studies showed that the observed coupling constants were in agreement with 
either R,R (Figure 1) or S,S configuration at C-6/C-9 but definitely not R,S or S,R (Supplementary Data 
S6-S13 and Table S1). Based on optical rotation trends of DKPs from the literature [3,7], the overall 
positive [α]21D = +12° indicated the absolute configuration at C-6 should be R, therefore supporting the 
R,R configuration. The magnitude of the optical rotation is also in agreement with other C-4 
hydroxylated DKPs [5,7]. The molecular model shown in Figure 1, with calculated dihedral angles for 
Ha-5–C-5–C-6–H-6 (Φ = 41°), Hb-5–C-5–C-6–H-6 (Φ = 163°), H-4–C-4–C-5–Ha-5 (Φ = 79°),  
H-4–C-4–C-5–Hb-5 (Φ = −42°), Ha-3–C-3–C-4–H-4 (Φ = 29°), Hb-3–C-3–C-4–H-4 (Φ = −93°) and  
8-NH–N-8–C-9–H-9 (Φ = 91°), best explained the observed COSY NMR correlations, 1H–1H 
coupling constants and the positive sign of [α]21D confirmed the absolute configuration at C-3, C-6 and 
C-8 to be as shown. It is likely that this DKP was produced by an enzymatically controlled 
condensation reaction between D-isoleucine and 4-S-hydroxy-D-proline (Scheme 1) [22]. 
Scheme 1. Structures of the bengazoles, bengamides and 1 isolated from Stelletta sp. and 
the proposed enzymatically controlled condensation reaction between D-isoleucine and  
4-S-hydroxy-D-proline to yield 1. 
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Figure 1. Minimum energy conformation of 1 obtained from MM2 calculations without 
applying any dihedral angle constraints [23]. The calculated dihedral angles for Hb-3–C-3–
C-4–H-4 (−93°), H-4–C-4–C-4–Ha-5 (79°) and for 8-NH–N-8–C-9–H-9 (91°), all which 
approximate 90° as observed experimentally from the 1H–1H coupling constants, are 
indicative of the absolute configurations at C-4 as being S and at both C-6 and C-9 being R. 
 
The cytotoxicity of 1–8 was investigated against the human tumour cell lines H460, SF-268,  
MCF-7, HT-29 and a normal mammalian cell line CHO-K1. The DKP 1 exhibited minimal activity 
towards MCF-7, H460 and HT-29 cells and no activity towards SF-268 or CHO-K1 cells at the highest 
dose (Table 2). In contrast, the GI50 values (µM) for bengamides A (2), F (3), N (4), Y(5), and 
bengazoles Z (6), C4 (7) and C6 (8) were comparable to those reported in previous studies [19,20], and 
accounted for the activity observed in the original MeOH extract. 
Table 2. GI50 (μM) data for compounds 1–8 against SF-268, MCF-7, H460, HT-29 and 
CHO-K1. 
No. SF-268 a MCF-7 b H460 c HT-29 d CHO-K1 e 
1 >295 204 234 270 >295 
2 <0.02 <0.02 <0.02 <0.02 0.1 
3 1.8 0.7 0.6 1.5 32 
4 <0.02 <0.02 <0.02 <0.02 0.2 
5 72 52 25 48 >184 
6 22 18 8 13 94 
7 0.3 0.8 0.1 0.6 1.2 
8 0.02 0.06 <0.02 0.1 0.8 
a SF-268 Central nervous system-glioblastoma cells; b MCF-7 Breast-pleural effusion 
adenocarcinoma cells; c H460 Lung-large cell carcinoma cells; d HT-29 Colon-recto-sigmoid colon 
adenocarcinoma cells; e CHO-K1 Sub-clone of Chinese hamster ovary cells. 
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3. Experimental 
3.1. General Experimental Procedures 
General experimental details have been described previously [29]. 
3.2. Animal Material 
This specimen of the sponge Stelletta sp., (Family Ancorinidae) was collected from the west side of 
Jamieson Reef, Bonaparte Archipelago, North West Western Australia, at depths ranging from 16 m to 
20 m, in August 1991. A voucher specimen (Accession number QMG312281) has been lodged with 
the Queensland Museum. 
3.3. Bioassay 
Cellular bioassays were undertaken as previously described [19]. 
3.4. Extraction and Isolation 
Freeze dried sponge material (125 g dry weight) was extracted sequentially with dichloromethane 
(CH2Cl2), MeOH and H2O; activity was confined to the CH2Cl2 and MeOH fractions. The MeOH 
fraction was subjected to reversed phase C18 flash vacuum chromatography (RP-C18, 40%, 60%, 
80%, 100% MeOH in H2O, and 100% CH2Cl2) with activity located in the 40% and 100%  
MeOH fractions. The 100% MeOH fraction was further separated using RP HPLC (4 mL/min, 
gradient elution from 60% acetonitrile (CH3CN):H2O (+0.1% formic acid [HCO2H]) to 100% CH3CN 
(+0.1% HCO2H) over 10 min, then isocratic 100% CH3CN (+0.1% HCO2H) for 15 min through a  
150 mm × 10 mm 5 μ Phenomenex Luna C18 column), to give thirteen fractions. The first active 
fraction, fraction 1, was subjected to RP HPLC (4 mL/min, gradient elution from 20% CH3CN:H2O 
(+0.1% HCO2H) to 100% CH3CN (+0.1% HCO2H) over 20 min through a 150 × 10 mm 5 μ 
Phenomenex Luna Phenyl-Hexyl column) to yield bengamide Y (5) (0.8 mg, 0.0006%). The additional 
active fractions 3 and 4 were both partitioned with n-hexane and MeOH (1:1) to yield bengamides  
N (4) (1.4 mg, 0.001%) and A (2) (3.3 mg 0.003%), respectively. 
The 40% MeOH fraction was subjected to further RP-C18 (10%, 20%, 30%, 40%, 50% and 100% 
MeOH in H2O) and the active fractions (30% and 40% MeOH) fractionated on RP HPLC (4 mL/min, 
gradient elution from 10% CH3CN:H2O (+0.1% HCO2H) to 64% CH3CN:H2O (+0.1% HCO2H)  
over 12 min, then isocratic 100% CH3CN (+0.1% formic acid) for an additional 5 min through a  
150 mm × 10 mm 5 μ Phenomenex Luna C18 column) to yield bengamide F (3, 2.1 mg, 0.002%), 
bengazoles Z (6, 5.0 mg, 0.004%), C4 (7) (13.8 mg, 0.011%) and C6 (8) (23.6 mg, 0.012%) and the 
new DKP cyclo-(4-S-hydroxy-R-proline-R-isoleucine) 1 (1.5 mg, 0.001%). 
3.4.1. Cyclo-(4-S-hydroxy-R-proline-R-isoleucine) (1) 
Isolated as a colourless oil. [α]21D +12° (c 0.025, CHCl3); IR (film) νmax 3391, 1649 cm−1;  
UV (PDA, CH3CN/H2O) λmax 220 nm; 1H (600 MHz, d6-DMSO) and 13C (150 MHz, d6-DMSO) NMR 
data see Table 1; ESI-FTMS [M + Na]+ 249.1203 (calcd. for C11H18N2O3Na 249.1215). 
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3.4.2. Bengamide A (2) 
Isolated as a colourless oil. 1H NMR and 13C NMR spectral data were consistent with published 
values [17]. 
3.4.3. Bengamide F (3) 
Isolated as a colourless oil. 1H NMR and 13C NMR spectral data were consistent with published 
values [18]. 
3.4.4. Bengamide N (4) 
Isolated as a colourless oil. 1H NMR and 13C NMR spectral data were consistent with published 
values [19]. 
3.4.5. Bengamide Y (5) 
Isolated as a colourless oil. 1H NMR and 13C NMR spectral data were consistent with published 
values [20]. 
3.4.6. Bengazole Z (6) 
Isolated as a colourless oil. 1H NMR and 13C NMR spectral data were consistent with published 
values [20]. 
3.4.7. Bengazole C4 (7) 
Isolated as a colourless oil. 1H NMR and 13C NMR spectral data were consistent with published 
values [21]. 
3.4.8. Bengazole C6 (8) 
Isolated as a colourless oil. 1H NMR and 13C NMR spectral data were consistent with published 
values [21]. 
4. Conclusion 
The DKP cyclo-(4-S-hydroxy-R-proline-R-isoleucine) (1), together with the known bengamides;  
A (2) , F (3), N (4), Y (5), and bengazoles; Z (6), C4 (7) and C6 (8), was isolated from the Australian 
marine sponge Stelletta sp. Interestingly, this is the first report of bengamides or bengazoles from  
the genus Stelletta, however, it should be noted that they have previously been reported from species 
of Dorypleres splendens [24], which has since been reclassified as Jaspis splendens, and from  
Jaspis sp. [24], both of which belong to the Ancorinidae family of sponges. The cyclo-(4-S-hydroxy-
R-proline-R-isoleucine) (1) was not cytotoxic against the cell lines MCF-7, H460, HT-29, SF-268 or 
CHO-K1. The DKP class of compounds has recently gained interest in drug discovery [25] due to their 
chiral, rigid and functionalised structures. These features enable them to bind to a large variety of 
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receptors with high affinity giving rise to a broad range of biological activities, including cytotoxicity, 
quorum sensing, antibacterial, antifungal, antiviral, antiprion, antitumor, and immunosuppressive 
functions, even plant-growth regulators [7,26–28]. Our report adds to the vast knowledge of these 
potentially therapeutic molecules. 
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